Table 3 Adverse events from baseline assessment to discharge assessment
From: Recumbent cycling to improve outcomes in people with hip fracture: a feasibility randomized trial
|  | Bike (n = 26) | Control (n = 25) |
|---|---|---|
Death | 2 (8%) | 1 (4%) |
ICU admission | 0 (0%) | 3 (16%) |
MET call | 6 (23%) | 10 (40%) |
Return to theatre | 1 (4%) | 0 (0%) |
Transfer to acute hospital | 1 (4%) | 2 (8%) |
Cardiac Event | 1 (4%) | 3 (16%) |
Bleeding | 3 (12%) | 1 (4%) |
Low HB | 8 (31%) | 8 (32%) |
Hypotension | 11 (42%) | 8 (32%) |
DVT | 0 (0%) | 0 (0%) |
PE | 2 (8%) | 0 (0%) |
Issues with fixation | 0 (0%) | 1 (4%) |
Chest Infection | 2 (8%) | 10 (40%) |
Urinary Tract infection | 2 (8%) | 0 (0%) |
Other infection | 3 (12%) | 0 (0%) |
Fall | 4 (15%) | 4 (15%) |
Pressure area | 1 (4%) | 2 (8%) |
Delirium | Â | Â |
 Within first seven daysa | 5 (22%) (n = 23) | 8 (35%) (n = 23) |
 Day 7b | 6 (30%) (n = 20) | 11 (48%) (n = 23) |
 Dischargeb | 8 (36%) (n = 22) | 8 (38%) (n = 21) |